Probiotic preparation based on porous microspheres as well as preparation method and application of probiotic preparation

Through co-culture of porous microspheres with probiotics and modification of tannin-Ca2+, combined with mucin and skim milk powder, the loss of activity of probiotic preparations in the environment and gastrointestinal tract is solved, and survival rate and stress resistance are improved. The preparation and application of high-efficiency probiotic preparations has been realized.

CN118903218APending Publication Date: 2024-11-08NANJING TECH UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410995930.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-24
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Probiotic preparations are susceptible to environmental and gastrointestinal factors during processing, storage and in vivo transmission, resulting in loss of activity. The existing freeze-drying technology may lead to cell structure damage during low temperatures and affect survival.

Method used

Porous microspheres were co-cultured with probiotics and filled culture, and the microspheres were modified by tannin-Ca2+ complex, combined with mucin and skim milk powder to enhance the stress resistance and survival rate of probiotics.

Benefits of technology

It significantly improves the survival rate and concentration of probiotics, extends the shelf life, enhances stress resistance and stability in the gastrointestinal tract, and ensures efficient application of probiotic preparations.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903218A_ABST
    Figure CN118903218A_ABST
Patent Text Reader

Abstract

The invention discloses a probiotic preparation based on porous microspheres as well as a preparation method and application of the probiotic preparation, porous structure microspheres are innovatively applied to preparation of the probiotic preparation in a direct adding manner, and filling type culture of strains is provided. The preparation method of the probiotic preparation comprises the following steps: (1) mixing porous microspheres with a tannic acid-Ca < 2 + > solution to obtain modified porous microspheres; (2) inoculating probiotics into a fermentation culture medium containing the modified porous microspheres for adhesion co-culture to obtain a first fermentation solution, replacing a fresh fermentation culture medium, and performing filling culture to obtain a second fermentation solution; and (3) centrifuging the second fermentation liquor, taking precipitate, adding a mucoprotein solution and a skim milk powder solution in sequence, and mixing to obtain the probiotic preparation. According to the probiotic preparation prepared by the preparation method provided by the invention, the adhesion of the probiotics in microsphere holes can be enriched, the content of the probiotics is greatly increased, and the activity of the probiotics is ensured.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of bioengineering technology, and in particular to a probiotic preparation based on porous microspheres, and a preparation method and application thereof. Background Art

[0002] Probiotics refer to single microorganisms or mixed microbial communities with a clear composition that produce benefits in the human body and thus have a health-promoting effect. They have great application value in promoting the digestion and absorption of nutrients, improving the body's immunity, and inhibiting intestinal inflammation. However, probiotic preparations are not only affected by external environmental factors such as humidity, temperature, pH value, and oxygen during processing and storage, but also by the internal environment when they enter the digestive system and pass through gastric juice, pepsin, trypsin, and bile salts to reach the colonization site to exert their effects, resulting in loss of activity. According to the Food and Agriculture Organization and the World Health Organization (FAO-WHO), the minimum number of probiotics required to achieve the desired effect should be 10. 7 CFU / g.

[0003] The preparation of probiotic preparations can protect probiotics from the influence of the external environment, thereby extending the shelf life, reducing storage conditions, improving their survival rate and efficacy, and making them easier to use and carry. Freeze-drying technology is widely used in the production of probiotic preparations. Compared with several other technologies, freeze-drying processing conditions are milder, but during the low-temperature freezing process, the formation of extracellular ice crystals and the increase in osmotic pressure will cause damage to the cell structure and organization, and a certain degree of cell inactivation will still occur.

[0004] Microspheres are micron-sized particles, usually made of polymers or inorganic materials, with high density and surface area. Currently, microspheres are mainly used in adsorption, drug molecule loading injection, and immobilized enzymes. For example, CN108715833B discloses a method for preparing chitosan-based microspheres, which can be used to embed drug molecules and improve the embedding rate and activity retention rate. CN101708463B discloses a method for preparing highly magnetically loaded conductive polymer microspheres, which can be used for the adsorption of heavy metal ions, with stable properties and fast adsorption speed.

[0005] Although microspheres have been widely used, there are few reports on the addition of microspheres with porous structures into probiotic preparations as the main structure. Based on the adsorption of probiotics by microspheres and the adhesion of probiotic biofilms, the stable microsphere structure can greatly increase the cell concentration and concentrate the distribution, produce a clustering effect and enhance stress resistance. Therefore, it is necessary to develop a probiotic preparation based on porous microspheres. Summary of the invention

[0006] Purpose of the invention: The technical problem to be solved by the present invention is to provide a probiotic preparation based on porous microspheres and its preparation method and application in view of the deficiencies of the prior art. 2+ The complex modified microspheres are co-cultured with probiotics and filled to obtain a mixture with a high bacterial concentration. The acid-resistant biomaterial mucin is modified through the interaction between tannic acid and protein, and finally the cryoprotectant skim milk powder is wrapped. This probiotic preparation can not only reduce the inactivation of probiotics in the digestive system, but also the addition of microspheres will cause the cells to be concentrated and produce a clustering effect to enhance stress resistance.

[0007] To achieve the above purpose, the technical solution adopted by the present invention is as follows:

[0008] A method for preparing a probiotic preparation based on porous microspheres comprises the following steps:

[0009] (1) The porous microspheres were mixed with tannic acid-Ca 2+ The solutions are mixed to obtain modified microspheres;

[0010] (2) inoculating the probiotics into a fermentation medium containing the modified microspheres for adhesion co-culture to obtain a first fermentation broth, replacing the fermentation medium with fresh one, performing filling culture to obtain a second fermentation broth;

[0011] (3) centrifuging the second fermentation liquid to obtain a precipitate, adding the mucin solution and the skimmed milk powder solution to the mixture, thereby obtaining a probiotic preparation;

[0012] Wherein, in step (1), the porous microspheres are any one or a combination of natural polymer-based, inorganic compound-based or synthetic polymer-based porous microspheres.

[0013] Wherein, in step (1), the size of the porous microsphere is 10-60 μm, the pore structure diameter is 3-10 μm, and the addition amount is 10-50 g / L. Preferably, the size of the porous microsphere is 20-50 μm, the pore structure diameter is 5-10 μm, and the addition amount is 36-50 g / L. Further preferably, the preparation method of the porous microsphere is detailed in Chinese patent CN103374143A.

[0014] Wherein, in step (1), the tannic acid-Ca 2+ The solution is prepared by mixing a tannic acid solution and a calcium chloride solution in a volume ratio of (1-5):(1-5); preferably, the calcium chloride is anhydrous calcium chloride. The volume ratio is 4:1.

[0015] Preferably, the solvent of the tannic acid solution is Tris-HCl buffer, the pH is 5.0-10.0, and the concentration is 1-10 g / L; the solvent of the calcium chloride solution is Tris-HCl buffer, the pH is 5.0-10.0, and the concentration is 1-10 g / L. Further preferably, the solvent of the tannic acid solution is Tris-HCl buffer, the pH is 7.4, and the concentration is 5 g / L; the solvent of the calcium chloride solution is Tris-HCl buffer, the pH is 7.4, and the concentration is 5 g / L.

[0016] Wherein, in step (1), the mixing time is 3 to 10 hours, preferably stirring at room temperature for 4 hours.

[0017] Wherein, in step (2), the probiotics include any one or a combination of Escherichia coli, lactic acid bacteria or Bacillus subtilis. Preferably, the probiotics are inoculated into the fermentation medium containing the modified microspheres in the form of probiotic seed liquid, and the initial OD of the probiotics after inoculation is 600 The value is 0.1.

[0018] Wherein, in step (2), the amount of the modified porous microspheres added is 0.01-0.05 g per mL of fermentation medium; preferably, 0.04 g of the modified microspheres is added per mL of fermentation medium.

[0019] The adhesion co-culture time is 8 to 18 hours, and the temperature is 30 to 37° C.; preferably, 12 to 16 hours, 35 to 37° C., and 120 to 250 rpm.

[0020] The filling culture time is 12 to 24 hours, and the temperature is 30 to 37° C.; preferably, 18 to 24 hours, 35 to 37° C., and 120 to 250 rpm.

[0021] Preferably, in step (2), the concentration of probiotics in the first fermentation broth obtained by co-cultivation is 10 4 ~10 6 CFU / mL; the method of replacing the fresh fermentation medium is: let the first fermentation liquid stand and settle, remove the upper free bacterial liquid, and add fresh fermentation medium. More preferably, the standing and settling time is 1 to 5 minutes. The filling culture is that the probiotics adhere to the inner wall and surface of the modified porous microspheres through co-culture and then replace the fresh fermentation medium to make the probiotics adhered to the microspheres proliferate in large quantities and increase the concentration;

[0022] Wherein, in step (3), the mucin solution is a PBS solution of mucin, and its concentration is 1 to 5 g / L; the added mass of the mucin is 1% to 10% of the mass of the modified porous microspheres described in step (2); preferably, the concentration of the mucin solution is 2 g / L, and the added mass of the mucin is 5% of the mass of the modified porous microspheres described in step (2).

[0023] The skimmed milk powder solution is a skimmed milk powder aqueous solution with a concentration of 5 to 15 g / L; the added mass of the skimmed milk powder is 10% to 50% of the mass of the modified porous microspheres in step (2); preferably, the concentration of the skimmed milk powder solution is 10 g / L; the added mass of the skimmed milk powder is 15% to 30% of the mass of the modified porous microspheres in step (2).

[0024] The mixing time is 0.5 to 6 hours. Preferably, the mixing time is 1 to 3 hours at room temperature.

[0025] Preferably, in step (3), the second fermentation liquid is centrifuged to obtain a precipitate, and a mucin solution and a skimmed milk powder solution are added and mixed successively, specifically: the second fermentation liquid is centrifuged to obtain a precipitate, and then the precipitate is washed with physiological saline 1 to 2 times, and then the mucin solution is added first to resuspend, and then stirred to obtain a first resuspended product, which is washed with physiological saline 1 to 3 times and then resuspended with skimmed milk powder solution, stirred to obtain a second resuspended product, washed with physiological saline 1 to 3 times, and freeze-dried to obtain a probiotic preparation. The freeze-drying is specifically pre-frozen at -20°C for 24 hours, and then frozen at -80°C for 8 to 16 hours.

[0026] In a second aspect, the present invention provides a probiotic preparation prepared by the preparation method described in the first aspect.

[0027] Wherein, the probiotic concentration in the probiotic preparation is 10 13 ~10 15 CFU / g.

[0028] In a third aspect, the present invention provides a use of the probiotic preparation described in the second aspect in the preparation of an intestinal medicine or a probiotic drink. Preferably, the intestinal medicine includes but is not limited to a probiotic tablet, capsule preparation, and oral liquid for preventing inflammatory bowel disease.

[0029] Among them, the present invention provides the concentration change of the probiotic preparation after passing through gastric acid and intestinal fluid.

[0030] Beneficial effects: Compared with the prior art, the present invention has the following beneficial effects:

[0031] (1) The present invention innovatively uses microspheres with a micron-sized pore structure in the preparation of probiotic preparations. By adding microspheres with a micron-sized pore structure in advance, a framework structure is provided for the adhesion and growth of probiotics. Compared with the preparation method of simultaneously preparing microspheres and encapsulating probiotics, the present invention avoids damage to the probiotics during the preparation process, can enrich the adhesion of probiotics in the pores of the microspheres, greatly increase the probiotic content, and ensure the activity of the probiotic preparation.

[0032] (2) In the present invention, the microspheres and probiotics are first co-cultured. The microspheres with a pore structure allow the probiotics to be simply adsorbed inside or on the surface of the microsphere pores. Using this structure as a seed, the culture medium is replaced for filling culture, which increases the concentration of probiotics in the microspheres, promotes the concentrated distribution of cells to produce a clustering effect to enhance stress resistance, and also lays a good foundation for the high concentration of bacteria in the probiotic preparation.

[0033] (3) In the present invention, before the microspheres are co-cultured with the probiotics, tannic acid-Ca 2+ Complex modification is used to enhance the initial adhesion of microspheres to probiotics, providing a basis for subsequent filling culture.

[0034] (4) After obtaining the filled probiotic microspheres, the present invention modifies the acid-resistant biomaterial mucin through the interaction between tannic acid and protein, which has strong resistance to the harsh environment of the gastrointestinal tract and can interact with the intestinal mucus layer through various interaction forces, thereby increasing the retention time of probiotics in the intestine. Finally, the cryoprotectant skimmed milk powder is wrapped to protect the activity retention of the probiotic preparation before and after freeze-drying. BRIEF DESCRIPTION OF THE DRAWINGS

[0035] The present invention will be further described in detail below in conjunction with the accompanying drawings and specific embodiments, and the above and / or other advantages of the present invention will become more clear.

[0036] Figure 1 This is a scanning electron microscope image of the microspheres with micrometer-scale pore structures used in the present invention.

[0037] Figure 2 The microspheres were treated with tannic acid-Ca 2+ Infrared comparison before and after chelation modification.

[0038] Figure 3 It is a scanning electron micrograph of the internal adhesion of microspheres after lactic acid bacteria filling culture and the prepared lactic acid bacteria probiotic preparation. Figure 3 a and Figure 3 b are scanning electron micrographs of the lactic acid bacteria in the microspheres obtained after filling culture. Figure 3 c is a scanning electron micrograph of the microspheres coated with mucin and skimmed milk powder.

[0039] Figure 4 The graph is a graph showing the change in the number of live bacteria of the probiotic preparations prepared in Examples 2-4 and Comparative Examples 1-3 during storage at different temperatures. Figure 4 a is the graph showing the change in viable bacterial count during storage at 4°C. Figure 4 b is the change of viable bacteria count during storage at 25°C.

[0040] Figure 5 The graph shows the change in the number of live bacteria of the probiotic preparations prepared in Examples 2-4 and Comparative Examples 1-3 before and after the ultraviolet stability test.

[0041] Figure 6 The changes in the number of live bacteria lost in the probiotic preparations prepared in Examples 2-4 and Comparative Examples 1-3 in in vitro gastrointestinal fluid simulation. DETAILED DESCRIPTION

[0042] The present invention can be better understood according to the following examples. The experimental methods in the following examples are conventional methods unless otherwise specified; the experimental materials used in the following examples are commercially available unless otherwise specified.

[0043] Example 1

[0044] The modification of micron-sized porous microspheres is carried out as follows:

[0045] (1) Take 1.2 g of porous microspheres, resuspend and wash twice with an appropriate amount of pure water, and then resuspend with 3 mL of pure water to obtain a porous microsphere suspension with a concentration of 0.4 g / mL for use. The preparation method of the porous microspheres is as follows: the porous microspheres prepared by the method described in Example 3 of Chinese Patent CN103374143A are placed at 3000 rpm and centrifuged for 8 minutes to obtain the porous microspheres used in the present invention.

[0046] (2) Prepare 30 mL of 50 mM Tris-HCl solution, adjust the pH to about 7.4 with dilute hydrochloric acid, add 0.15 g of tannic acid, and obtain a tannic acid solution with a tannic acid concentration of 5 g / L. Prepare 10 mL of 50 mM Tris-HCl solution, adjust the pH to about 7.4 with dilute hydrochloric acid, add 0.05 g of anhydrous calcium chloride, and obtain a calcium chloride solution with a calcium chloride concentration of 5 g / L.

[0047] (3) Mixing 24 mL of tannic acid solution prepared in step (2) and 6 mL of calcium chloride solution in a volume ratio of 4:1 to obtain tannic acid-Ca 2+ Solution.

[0048] (4) Take 3 mL of the porous microsphere suspension prepared in step (1) and add the tannic acid-Ca 2+The modified porous microspheres were washed twice with pure water, and the precipitate was collected by centrifugation and dried in an oven at 55°C for later use.

[0049] The porous microspheres are Figure 1 As shown, most of the microspheres are 20-50 μm in size and have a pore size of 3-10 μm. 2+ The infrared spectra of the chelate modification before and after are as follows: Figure 2 As shown, line a is tannic acid-Ca 2+ The chelated microspheres are modified, and the spectrum b is the unmodified microspheres. The 3400cm -1 The vibration peak of -OH of tannic acid is obvious at 1620 cm -1 Due to the successful modification of tannic acid, the C=O vibration peak is significantly enhanced and shifted. In addition, the peak at 1480cm -1 、1250cm -1 , 1000cm -1 There are also phenomena such as the disappearance of peaks, the appearance of new peaks, and shifts in other places. This may be because the surface groups of the original microspheres react with tannic acid to consume various groups and introduce new groups due to successful modification, and the chelation of metal ions causes the vibration peaks to shift. This shows that tannic acid-Ca 2+ The chelation modified microspheres were successful.

[0050] Example 2

[0051] A method for preparing a probiotic preparation based on porous microspheres comprises the following steps:

[0052] (1) The overnight cultured lactic acid bacteria seed solution was transferred to 20 mL of MRS medium containing the modified porous microspheres prepared in Example 1 at an inoculum volume of 10 vt%, so that the initial OD 600 was 0.1, and adhesion co-culture was carried out at 37°C and 200 rpm for 12 h, wherein the content of the modified microspheres was 0.8 g.

[0053] (2) After the co-culture is completed, the culture flask is removed and allowed to settle for 2 min. The upper free bacterial liquid is removed with a pipette, and 20 mL of MRS medium is added again. The lactic acid bacteria cells adhered to the microspheres are used as seeds, and the culture is carried out at 37°C and 200 rpm for 24 h.

[0054] (3) After the filling culture, the precipitate was centrifuged and resuspended in physiological saline and washed twice, then resuspended in 20 mL of 2 g / L mucin solution and gently stirred for 3 h at room temperature. The mucin solution was 40 mg of mucin (purchased from Shanghai Yuanye Biotechnology Co., Ltd., product number s12066-5g) dissolved in 20 mL of PBS (pH = 7.0) solution.

[0055] (4) After mucin modification, the precipitate was centrifuged and resuspended in physiological saline and washed twice, then resuspended in 20 mL of 10 g / L skim milk powder solution and modified with gentle stirring at room temperature for 1.5 h. The skim milk powder solution was 0.2 g skim milk powder dissolved in 20 mL of pure water.

[0056] (5) After the skimmed milk powder coating is completed, the precipitate is centrifuged and resuspended with physiological saline, washed once, and then pre-frozen at -20°C for 24 hours, then frozen at -80°C for 14 hours, and then dried by freeze drying to obtain a lactic acid bacteria probiotic preparation powder, which is recorded as A-1.

[0057] The state of lactic acid bacteria in the microspheres after the filling culture in step (2) is as follows Figure 3 (a) and Figure 3 As shown in (b), a large number of lactic acid bacteria can be seen adhering to the internal pore structure of the microspheres through the formation of biofilm. Figure 3 (c) are microspheres coated with mucin and skimmed milk powder, which provide protection for probiotics during freeze drying and gastrointestinal fluid digestion.

[0058] The filled culture microspheres and probiotic preparations obtained in the following embodiments and comparative examples are basically the same as these, with slight differences manifested in different adhesion amounts in the microsphere pore structure caused by different film-forming abilities of different strains.

[0059] Example 3

[0060] A method for preparing a probiotic preparation based on porous microspheres comprises the following steps:

[0061] The lactic acid bacteria in Example 2 were replaced by Escherichia coli, the co-culture time was adjusted to 8 h, the filling culture time was adjusted to 14 h, the culture medium was replaced by LB culture medium: peptone 10 g / L, sodium chloride 10 g / L, yeast powder 5 g / L, and the remaining steps were the same as in Example 2 to prepare an Escherichia coli probiotic preparation, recorded as A-2.

[0062] Example 4

[0063] A method for preparing a probiotic preparation based on porous microspheres comprises the following steps:

[0064] The lactic acid bacteria in Example 2 were replaced with Bacillus subtilis, the co-culture time was adjusted to 12 h, the filling culture time was adjusted to 36 h, the culture medium was replaced with LB culture medium: peptone 10 g / L, sodium chloride 10 g / L, yeast powder 5 g / L, and the remaining steps were the same as in Example 2 to prepare a Bacillus subtilis probiotic preparation, recorded as A-3.

[0065] Comparative Example 1

[0066] The preparation method of a lactic acid bacteria probiotic preparation without adding microspheres comprises the following steps:

[0067] In this comparative example, the process of adding microspheres in step (1) of Example 2 was removed. Specifically, the overnight cultured lactic acid bacteria seed liquid was transferred to 20 mL of new MRS medium at an inoculation rate of 10 vt%. The culture conditions and time remained unchanged. The remaining steps were the same as in Example 2 to prepare a lactic acid bacteria probiotic preparation without microspheres, which was recorded as B-1.

[0068] Comparative Example 2

[0069] A method for preparing a probiotic preparation based on porous structure microspheres comprises the following steps:

[0070] In this comparative example, the modified microspheres added in step (1) of Example 2 were replaced by unmodified microspheres that had only been washed twice with pure water. The remaining steps were the same as those in Example 2 to prepare a lactic acid bacteria probiotic preparation, which was recorded as B-2.

[0071] Comparative Example 3

[0072] The preparation method of the probiotic preparation of microporous microspheres comprises the following steps:

[0073] The average pore size of the microporous structure microspheres used in this comparative example is less than 1.5 μm (the synthesis method of the microspheres refers to Example 1 of patent CN103374143A), and normal microbial cells cannot enter the interior of the microspheres.

[0074] The modified microspheres with microporous structure were obtained in the same way as in Example 1, and then the lactic acid bacteria probiotic preparation was obtained in the same way as in Example 2, which was recorded as B-3.

[0075] The probiotic preparations prepared in Examples 2-4 and Comparative Examples 1-3 were stored at 4° C. and 25° C. in sealed centrifuge tubes, respectively. The number of viable bacteria was counted by plate counting method every 5 days, and the change in the number of viable bacteria (log CFU / g) within 30 days was detected.

[0076] Under 4°C storage conditions, the viable counts of the probiotic preparations A-1, A-2, A-3 prepared in Examples 2-4 and the probiotic preparations B-1, B-2, B-3 in the comparative example fluctuated slightly within 30 days. Figure 4 As shown in (a), A-1, A-2, and A-3 showed almost no activity change, and the number of live bacteria changed within 0.5 log CFU / g after freeze-drying until 30 days of storage. A-1 had the highest number of live bacteria of 12.3 log CFU / g after freeze-drying due to the excellent film-forming ability of lactic acid bacteria in microspheres. The film-forming ability of Escherichia coli and Bacillus subtilis in A-2 and A-3 was slightly weaker, resulting in the number of live bacteria in the probiotic preparations being slightly lower than that of A-1, but also around 11.7 log CFU / g. B-1 and B-2 did not add microspheres and the The added microspheres were not surface modified, and the number of live bacteria decreased slightly in the later stage of storage, with an overall change of about 1.0logCFU / g. In B-3, since microspheres with a microporous structure with a very small pore size were added, the microbial cells could only adhere to the surface of the microspheres to form a film in small quantities, but could not reach the inside of the microspheres. Compared with other control samples of the same quality, the microbial cell content was lower, and the film formation of a small amount of microbial cells still played a protective role in the storage of the preparation. The loss within 30 days was slightly greater than 0.5logCFU / g, which was better than the preparation without microspheres. By comparing B-1 with A-1, it can be clearly seen that in the probiotic preparation B-1 without the addition of microspheres, the number of live bacteria was much lower than that of A-1 as a whole. The reason may be the lack of filling culture in the microspheres, which made the initial bacterial concentration low. The lack of protection of the microspheres during the freeze-drying stage caused the number of live bacteria to decrease again. After 15 days, the rate of decrease in the number of live bacteria in B-1 was faster than that in the other preparations. In the comparison between B-2 and A-1, the initial bacterial concentration of B-2 was lower than that of A-1. The reason may be that the unmodified microspheres made the initial adhesion ability of lactic acid bacteria slightly weaker.

[0077] Under the storage condition of 25°C, the viable counts of the probiotic preparations A-1, A-2, A-3 prepared in Examples 2-4 and the probiotic preparations B-1, B-2, B-3 in the comparative example all showed a significant downward trend within 30 days. Figure 4 As shown in (b), however, due to the protection of microspheres, the viable count of A-1, A-2, A-3, and B-2 changed to about 1.0logCFU / g. Due to the effect of microfilm formation, even though the initial microbial cell content of B-3 was lower than that of B-1, the cell content after 30 days was slightly higher than that of B-1. The viable count of A-1, which had the best effect, was still maintained at 11.5logCFU / g. B-1 reached the lowest value of 5.9logCFU / g on the 30th day due to the absence of microspheres.

[0078] It can be seen that after modification, the porous structure microspheres can effectively improve the bacterial concentration in the probiotic preparation under filling culture conditions and the storage capacity at low temperature 4°C and normal temperature 25°C.

[0079] The probiotic preparations prepared in Examples 2-4 and Comparative Examples 1-3 were subjected to UV stability test. 1 g of the probiotic preparation and 1 mL of the corresponding bacterial suspension (the preparation method of the bacterial suspension is: inoculating the strain seed liquid into the corresponding culture medium, and culturing the culture medium according to the culture temperature, time, and culture medium used in the co-culture method corresponding to the strains, and 1 mL is sufficient) were added to a sterilized centrifuge tube, and all were exposed to 253.7 nm ultraviolet light for 30 minutes, and then placed for 30 minutes. After the end, they were transferred to 9 mL of sterilized PBS buffer (pH = 7.0), gradiently diluted and coated on a plate for counting, and the survival rate was expressed by comparing the number of live bacteria before and after ultraviolet light irradiation. The formula is:

[0080]

[0081] Free lactic acid bacteria, Escherichia coli, and Bacillus subtilis suspensions were denoted as naked bacteria 1, naked bacteria 2, and naked bacteria 3, respectively. The probiotic preparations were denoted in the same manner as above. The results are shown in Tables 1 and Figure 5 shown.

[0082] Table 1 Changes in the number of viable bacteria before and after UV stability determination

[0083]

[0084] Free microorganisms may induce the formation of thymine dimers due to ultraviolet radiation, causing all microorganisms to die in a short period of time. B-1 has no microsphere protection, but it can still maintain a certain survival rate due to modifications such as freeze-drying protective agents. B-3 also has no protection from porous microspheres, and the survival rate of microbial cells is low. Under the protection of unmodified microspheres, the survival rate of B-2 can reach 78.69%, which has a significant advantage over B-1. A-1, A-2, and A-3 have a survival rate of about 85% under the protection of modified microspheres. This can be attributed to the shielding of ultraviolet rays by microspheres, and the role of biofilms in microbial aggregates formed by this filling culture or quorum sensing to enhance the stress resistance of microorganisms.

[0085] The probiotic preparations prepared in Examples 2-4 and Comparative Examples 1-3 were subjected to in vitro simulated digestion experiments.

[0086] (1) Take 10 g of pepsin and 16.4 mL of dilute hydrochloric acid, add ultrapure water, mix well and dilute to 1000 mL to obtain simulated gastric fluid; the pepsin was purchased from Shanghai MacLean Biochemical Technology Co., Ltd., and the enzyme activity was 3000 U / mg.

[0087] Take 6.8g of potassium dihydrogen phosphate, add 500mL of water to dissolve it, and adjust the pH value to 6.8 with 0.1mol / L sodium hydroxide solution; take 10.0g of trypsin, add appropriate amount of water to dissolve it, mix the two liquids, and dilute with water to 1000mL to obtain simulated intestinal fluid. The trypsin was purchased from Shanghai McLean Biochemical Technology Co., Ltd., and the enzyme activity is 250U / mg. (2) Filter the prepared simulated gastric fluid and simulated intestinal fluid (0.22μm water filter membrane) for sterilization.

[0088] (3) 0.2 g of each probiotic preparation was mixed with 10 mL of simulated gastric fluid and placed in a 37°C water bath shaker at 150 rpm for 2 h to simulate the gastric digestion process. A parallel sample was taken every 0.5 h to determine the number of viable bacteria.

[0089] (4) The mixture after simulated gastric juice digestion was centrifuged to obtain the precipitate, 10 mL of simulated intestinal fluid was added, and the mixture was placed in a 37°C water bath shaker at 150 rpm for 4 h to simulate the intestinal digestion process. A parallel sample was taken every 1 h to determine the number of viable bacteria.

[0090] Before the digestion simulation experiment began, except for B-1 without microspheres and B-3 with microporous microspheres, A-1, A-2, A-3 and B-2 maintained a high number of live bacteria above 12.0logCFU / g during the freeze-drying process due to the protection of microspheres. During the entire gastric digestion process, each probiotic preparation had a different degree of reduction, but A-1, A-2, A-3, and B-2 with microspheres showed excellent gastric acid resistance during gastric digestion, and the reduction of live bacteria was controlled within 1.0logCFU / g, while B-1 showed extremely poor resistance within 2 hours of gastric digestion, with a loss of about 8.2logCFU / g, and almost all live bacteria died. Because B-3 added microspheres with microporous structures, microbial cells can form a film on the surface of the microspheres, making the resistance slightly stronger than B-1, but the cell content in the probiotic preparation was also lower than other comparative examples. After collecting the sediment after gastric digestion and adding simulated intestinal fluid to continue simulating the digestion process, the number of live bacteria in each embodiment and comparative example still showed a downward trend, but the loss trend of the number of live bacteria in groups A-1, A-2, A-3, and B-2 with porous structure microspheres was extremely slow. The reason is that when a part of the probiotic cells are inactivated in the harsh environment, the microspheres also slowly release probiotics in the intestinal fluid environment. This makes the number of live bacteria in each group still maintain a high level of 10.0logCFU / g and above after the simulated intestinal digestion is completed. Figure 6It can be seen that after 1 hour of simulated intestinal digestion, the number of live bacteria lost in probiotic preparation B-1 (without microspheres) reached 6.1logCFU / g, the number of live bacteria lost in probiotic preparation B-2 (with unmodified microspheres) reached 0.39logCFU / g, and the number of live bacteria lost in probiotic preparation A-1 (with modified microspheres) reached 0.3logCFU / g. After 6 hours of simulated intestinal digestion, the number of live bacteria lost in probiotic preparation B-1 (without microspheres) reached 8.2logCFU / g, the number of live bacteria lost in probiotic preparation B-2 (with unmodified microspheres) reached 1.25logCFU / g, and the number of live bacteria lost in probiotic preparation A-1 (with modified microspheres) reached 0.91logCFU / g.

[0091] The present invention provides a probiotic preparation based on porous microspheres and a preparation method and application thereof. There are many methods and approaches to implement the technical solution. The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the protection scope of the present invention. All components not specified in this embodiment can be implemented by existing technologies.

Claims

1. A method for preparing a probiotic preparation based on porous microspheres, characterized in that: The following steps are involved: (1) The porous microspheres were mixed with tannic acid-Ca 2+ The solutions are mixed to obtain modified porous microspheres; (2) inoculating the probiotics into a fermentation medium containing the modified porous microspheres for adhesion co-culture to obtain a first fermentation liquid, replacing the fermentation medium with fresh one, performing filling culture to obtain a second fermentation liquid; (3) The second fermentation liquid is centrifuged to obtain a precipitate, and the mucin solution and the skimmed milk powder solution are added successively and mixed to obtain a probiotic preparation.

2. The preparation method according to claim 1, characterized in that: In step (1), the porous microspheres are any one or a combination of natural polymer-based, inorganic compound-based or synthetic polymer-based porous microspheres.

3. The preparation method according to claim 1, characterized in that: In step (1), the diameter of the porous microspheres is 10 to 60 μm, the aperture of the pore structure is 3 to 10 μm, and the added amount is 10 to 50 g / L.

4. The preparation method according to claim 1, characterized in that: In step (1), the tannic acid-Ca 2+ The solution is prepared by mixing tannic acid solution and calcium chloride solution in a volume ratio of (1-5):(1-5); Preferably, the tannic acid solution has a solvent of Tris-HCl buffer, a pH of 5.0 to 10.0, and a concentration of 1 to 10 g / L; The solvent of the calcium chloride solution is Tris-HCl buffer, the pH value is 5.0-10.0, and the concentration is 1-10 g / L.

5. The preparation method according to claim 1, characterized in that: In step (1), the mixing time is 3 to 10 hours.

6. The preparation method according to claim 1, characterized in that: In step (2), the probiotics include any one or a combination of Escherichia coli, lactic acid bacteria or Bacillus subtilis.

7. The preparation method according to claim 1, characterized in that: In step (2), the amount of the modified porous microspheres added is 0.01 to 0.05 g per mL of fermentation medium; The adhesion co-culture time is 8 to 18 hours, and the temperature is 30 to 37° C.; The filling culture time is 12 to 24 hours, and the temperature is 30 to 37°C.

8. The preparation method according to claim 1, characterized in that: In step (3), the solvent of the mucin solution is PBS, the concentration is 1 to 5 g / L, and the added mass of the mucin is 1% to 10% of the mass of the modified porous microspheres described in step (2); The skimmed milk powder solution has a solvent of water and a concentration of 5 to 15 g / L. The added mass of the skimmed milk powder is 10% to 50% of the mass of the modified porous microspheres in step (2); The mixing time is 0.5 to 6 hours.

9. The probiotic preparation obtained according to the preparation method according to any one of claims 1 to 8.

10. Use of the probiotic preparation according to claim 9 in the preparation of intestinal medicines or probiotic drinks.